California Public Employees Retirement System Avidity Biosciences, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.62 - $29.26 $580,752 - $866,096	-29,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$20.28 - $28.15 $55,161 - $76,568	-2,720 Reduced 8.42%	29,600 $646,000
Q4 2020 Feb 02, 2021	SELL	$24.73 - $35.12 $14,838 - $21,072	-600 Reduced 1.82%	32,320 $825,000
Q3 2020 Nov 05, 2020	BUY	$23.35 - $35.94 $768,682 - $1.18 Million	32,920 New	32,920 $927,000

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

Price T Rowe Associates Inc Baltimore, MD

10.6M
Shares

$384 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

9.23M
Shares

$333 Million
0.01% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$311 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

8.13M
Shares

$294 Million
5.95% of portfolio
Wellington Management Group LLP Boston, MA

7.03M
Shares

$254 Million
0.06% of portfolio

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.88B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account